Profile for Rigel Pharmaceuticals Inc. (RIGL)

$ 1.64   -0.05 (-2.96%) Volume: 2.84m 4:00 PM EDT 16-Oct-2019
After Hours:  $ 1.65   0.01 (+0.61%) Volume: 431.81k 5:49 PM EDT 16-Oct-2019
Business Description:
Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company. It discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.
Address: 1180 Veterans Boulevard, South San Francisco, CA, USA, 94080
Telephone: +1 650 624-1100 Website:
Facsimile: +1 650 624-1101 Email: [email protected]
CEO: Raul R. Rodriguez
Employees: 156 Market Cap: 274.88m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion
Indices: Biotechnology, Morningstar US Market Factor Tilt PR USD, Morningstar US Market Factor Tilt TR USD
Industry Classifications
Sector: Healthcare CIK: 1034842
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)